Loading…
Fermenta Biotech (FERMENTA)₹430.45−5.40%Pharmaceuticals
At the end of the Sep 2026 quarter, Fermenta Biotech's shareholders were: promoters 64.08%, FIIs 0.37%, DIIs 0.04%, public 32.98%, others 2.53%. Promoter holding is up 0.01 percentage points from 64.07% a quarter earlier. FII holding is up 0.35 percentage points from 0.02% a year earlier. It had 14,771 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 62.05% | 62.05% | 62.05% | 62.05% | 62.05% | 64.07% | 64.07% | 64.07% | 64.07% | 64.07% | 64.07% | 64.08% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.05% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.13% | 0.37% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.04% | 0.04% |
| Public | 36.08% | 36.08% | 36.15% | 36.44% | 37.00% | 35.03% | 35.03% | 34.78% | 34.03% | 33.35% | 33.23% | 32.98% |
| Others | 1.87% | 1.87% | 1.80% | 1.46% | 0.93% | 0.88% | 0.88% | 1.13% | 1.88% | 2.56% | 2.53% | 2.53% |
| Number of shareholders | 15,144 | 15,172 | 14,583 | 13,216 | 12,917 | 12,925 | 12,840 | 13,755 | 14,133 | 13,656 | 14,125 | 14,771 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Krishna Datla | Promoter | 36.06% | 0.00 |
| Satish Varma Azad Nadimpally | Promoter | 11.78% | 0.00 |
| Anupama Datla Desai | Promoter | 8.71% | 0.00 |
| Preeti Thakkar | Promoter | 7.62% | 0.00 |
| Rakesh Kantilal Shah | Public | 1.70% | −0.04 |
| Krishan Premnarayen | Public | 1.37% | 0.00 |
| Investor Education and Protection Fund (IEPF) | Public | 0.61% | New |
| Unclaimed or Suspense or Escrow Account | Public | 0.16% | New |
| Independent Director or his relatives | Public | 0.02% | New |
Promoters held 64.08% of Fermenta Biotech at the end of the Sep 2026 quarter, up 0.01 percentage points from 64.07% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 0.37% (up 0.24 percentage points from 0.13% a quarter earlier) and domestic institutions (DIIs) held 0.04% (unchanged at 0.04% a quarter earlier).
Fermenta Biotech had 14,771 shareholders at the end of the Sep 2026 quarter, against 13,755 a year earlier.
Rakesh Kantilal Shah (Public) held 1.70% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.